• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Development of therapeutic therapy for regression of cardiac hypertrophy in hypertrophic cardiomyopathy

Research Project

  • PDF
Project/Area Number 22659154
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeSingle-year Grants
Research Field Circulatory organs internal medicine
Research InstitutionYamaguchi University

Principal Investigator

YANO Masafumi  山口大学, 医学部附属病院, 講師 (90294628)

Co-Investigator(Kenkyū-buntansha) YAMAMOTO Takeshi  山口大学, 大学院・医学系研究科, 助教 (50363122)
IKEDA Yasuhiro  山口大学, 大学院・医学系研究科, 助教 (00260349)
Project Period (FY) 2010 – 2011
Keywords肥大型心筋症 / カルシウムハンドリング
Research Abstract

Hypertrophic cardiomyopathy(HCM) is known to be a myocardial disorder characterized by idiopathic hypertrophy of the left ventricule. In HCM patients, sudden death occurs owing to lethal arrhythmia in young age and diastolic heart failure can be sometimes developed. Medical approach for regression of hypertrophy in HCM patients remains elusive. Here, we hypothesized that diastolic Ca2+ leak through ryanodine receptor(RyR2) might predispose to abnormal hypertrophy in HCM patients. To verify this hypothesis, we investigated the pathogenic role of Ca2+ leak through RyR2 in transgenic mouse(TG) model of familial hypertrophic cardiomyopathy-related cardiac troponin T mutation. Diastolic Ca2+ leak through defective RyR2 is induced by beta-adrenergic stimulation in TG cardiomyocytes. Dantrolene, which was found to stabilize RyR2 inhibited Ca2+ leak. These results suggest that stabilization of RyR2 and subsequent inhibition of Ca2+ leak might play a pivotalrole for regression of abnormal hypertrophy in HCM patients.

  • Research Products

    (19 results)

All 2011 2010 2009

All Journal Article (6 results) (of which Peer Reviewed: 6 results) Presentation (11 results) Book (2 results)

  • [Journal Article] Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca^<2+> release leading to catecholaminergic polymorphic2011

    • Author(s)
      Suetomi T, Yano M, Uchinoumi H, Fukuda M, Hino A, Ono M, Xu X, Tateishi H, Okuda S, Doi M, Kobayashi S, Ikeda Y, Yamamoto T, Ikemoto N, Matsuzaki M.
    • Journal Title

      ventricular tachycardia. Circulation

      Volume: 124(6) Pages: 682-94

    • Peer Reviewed
  • [Journal Article] Urinary8-hydroxy-2'-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure2011

    • Author(s)
      Kobayashi S, Susa T, Tanaka T, Wada Y, Okuda S, Doi M, Nao T, Yoshiga Y, Yamada J, Okamura T, Ueyama T, Kawamura S, Yano M, Matsuzaki M
    • Journal Title

      Eur J Heart Fail

      Volume: 13(1) Pages: 29-36

    • Peer Reviewed
  • [Journal Article] Matsuzaki M. Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Inhibits Catecholaminergic2010

    • Author(s)
      Kobayashi S, Yano M, Uchinoumi H, Suetomi T, Susa T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Yamamoto T
    • Journal Title

      Polymorphic Ventricular Tachycardia in a RyR2(R2474S/+) Knock-In Mouse Model. Circ J

      Volume: 74 Pages: 2579-84

    • Peer Reviewed
  • [Journal Article] Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction2010

    • Author(s)
      Xu X, Yano M, Uchinoumi H, Hino A, Suetomi T, Ono M, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ikemoto N, Matsuzaki M
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 394 Pages: 660-6

    • Peer Reviewed
  • [Journal Article] Catecholaminergic Polymorphic Ventricular Tachycardia Is Caused by Mutation-Linked Defective Conformational Regulation of the2010

    • Author(s)
      Uchinoumi H, Yano M, Suetomi T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M
    • Journal Title

      Ryanodine Receptor. Cir Res

      Volume: 106 Pages: 1413-24

    • Peer Reviewed
  • [Journal Article] Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca2+ releasein heart failure2010

    • Author(s)
      Ono M, Yano M, Hino A, Suetomi T, Xu X, Susa T, Uchinoumi H, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M
    • Journal Title

      Cardiovasc Res

      Volume: 87 Pages: 609-17

    • Peer Reviewed
  • [Presentation] Coupled Conformational Changes in the Local and Global Inter-Domain Interactions Trigger Diastolic Ca2+ Release and Lethal Arrhythmia in Catecholaminergic Polymorphic Ventricular Tachycardia(CPVT)2011

    • Author(s)
      Suetomi T, Yano T, Kato T, Fukuda M, Hino A, Doi M, Okuda S, Kobayashi S, Ikeda Y, Yamamoto T, Matsuzaki M
    • Organizer
      American Heart association Scientific meeting 2011
    • Place of Presentation
      Orland, USA
    • Year and Date
      2011-11-15
  • [Presentation] Matsuzaki M. Enhancement of Calmodulin Binding to RyR2 Inhibits Aberrant Ca2+ Release in CPVT-Associated Mutation2011

    • Author(s)
      Fukuda M, Yano M, Kato T, Hino A, Suetomi T, Doi M, Okuda S, Kobayashi S, Ikeda Y, Yamamoto T
    • Organizer
      American Heart association Scientific meeting
    • Place of Presentation
      Orland, USA
    • Year and Date
      2011-11-14
  • [Presentation] Urinary 8-hydroxy-2'-deoxyguanosine as a Novel Biomarker of Inflammatory Activity in Patients with Cardiac Sarcoidosis : Insight From Immunohistochemical Technique and 18F-FDG PET/ CT2011

    • Author(s)
      Fukuta S, Kobayashi S, Tanaka T, Susa T, Murakami W, Okuda S, Doi M, Wada Y, Nao T, Yamada J, Ueyama T, Okamura T, Kawamura S, Yano M, Matsuzaki M
    • Organizer
      American Heart association Scientific meeting 2011
    • Place of Presentation
      Orland, USA
    • Year and Date
      2011-11-14
  • [Presentation] Structure-based drug design to modulate RyR2 function2011

    • Author(s)
      Yano M.
    • Organizer
      American Heart association Scientific meeting 2011
    • Place of Presentation
      Orland, USA
    • Year and Date
      2011-11-13
  • [Presentation] Correction of Defective Calmodulin Binding to Cardiac Ryanodine Receptor Inhibits Aberrant Ca2+ Release in CPVT-associated Mutation2010

    • Author(s)
      Fukuda M, Yano M, Hino A, Suetomi T, Xu X, Ono M, Uchinoumi H, Doi M, Okuda S, Kobayashi S, Yamamoto T, Matsuzaki M
    • Organizer
      Inhibits Aberrant Ca^<2+> Release in CPVT-associated Mutation American Heart association Scientific meeting 2010
    • Place of Presentation
      Chicago, USA
    • Year and Date
      2010-11-17
  • [Presentation] Mutation-linked Defective Domain Interaction within the Ryanodine Receptor Causes Ca^<2+> Leak Leading to Catecholaminergic Polymorphic Ventricular Tachycardia2010

    • Author(s)
      Suetomi T, Yano M, Fukuda M, Hino A, Ono M, Xu X, Susa T, Uchinoumi H, Oda T, Okuda S, Kobayashi S, Yamamoto T, Ikeda Y, Matsuzaki M
    • Organizer
      American Heart association Scientific meeting 2010
    • Place of Presentation
      Chicago, USA
    • Year and Date
      2010-11-17
  • [Presentation] Increased Affinity of Calmodulin Binding to Cardiac Ryanodine Receptor Corrects the Defective Channel Gating in Failing Hearts2010

    • Author(s)
      Hino A, Yano M, Fukuda M, Suetomi T, Ono M, Xu X, Uchinoumi H, Susa T, Doi M, Okuda S, Kobayashi S, Yamamoto T, Matsuzaki M
    • Organizer
      American Heart association Scientific meeting 2010
    • Place of Presentation
      Chicago, USA
    • Year and Date
      2010-11-16
  • [Presentation] Correction of Defective Inter-domain Interaction Within the Cardiac Ryanodine Receptor as a New Therapeutic Strategy Against Catecholaminergic Polymorphic Ventricular Tachycardia(CPVT)2009

    • Author(s)
      Uchinoumi H, Yano M, Hino A, Suetomi T, Ono M, Xu X, Oda T, Doi M, Okuda S, Kobayashi S, Yamamoto T, Ikeda Y, Matsuzaki M
    • Organizer
      American Heart association Scientific meeting 2009
    • Place of Presentation
      Orlando, USA
    • Year and Date
      2009-11-18
  • [Presentation] Low-dose ofβBlocker Improves Cardiac Function in Patients With Acute Heart Failure Partly by Inhibiting Ca^<2+> Leak Through the Ryanodine Receptor2009

    • Author(s)
      Kobayashi S, Tanaka T, Susa T, Ono M, Uchinoumi H, Okuda S, Doi M, Kawamura S, Yamamoto T, Yano M, Matsuzaki M.
    • Organizer
      American Heart association Scientific meeting 2009
    • Place of Presentation
      Orlando, USA
    • Year and Date
      2009-11-18
  • [Presentation] Mutation-linked Channel Disorder in Catecholaminergic Polymorphic Ventricular Tachycardia(CPVT) is Caused by Abnormally Tight Domain-Domain2009

    • Author(s)
      Suetomi T, Yano M, Hino A, Ono M, Xu X, Susa T, Uchinoumi H, Oda T, Doi M, Okuda S, Kobayashi S, Ikeda Y, Yamamoto T, Matsuzaki M
    • Organizer
      Interaction in RyR2 American Heart association Scientific meeting 2009
    • Place of Presentation
      Orlando, USA
    • Year and Date
      2009-11-17
  • [Presentation] Decreased Affinity of Calmodulin to RyR2 May Be a Sauce Mechanism of Leaky Channel in CPVT-associated Mutation2009

    • Author(s)
      Xu X, Yano M, Hino A, Suetomi T, Ono M, Uchinoumi H, Oda T, Doi M, Okuda S, Kobayashi S, Ikeda Y, Yamamoto T, Ohkusa T, Matsuzaki M
    • Organizer
      American Heart association Scientific meeting 2009
    • Place of Presentation
      Orlando, U. S. A.
    • Year and Date
      2009-11-16
  • [Book] シグナル伝達系からみた心不全の機序と治療戦略, Cardioligy Frontier2011

    • Author(s)
      奥田真一、矢野雅文
    • Total Pages
      129-137
    • Publisher
      メディカルレビュー社
  • [Book] 不全心筋における逆リモデリングの分子生物学的機序,呼吸と循環2010

    • Author(s)
      奥田真一、矢野雅文
    • Total Pages
      657-666
    • Publisher
      医学書院

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi